Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Objective: To characterize the initial presentation and clinical course of patients with hepatocyte nuclear factor (HNF) 4A‒ and HNF1B‒MODY in a multinational registry. Design, Setting, and Participants: Within the Diabetes Patienten Verlaufsdokumentation (DPV) registry, 44 patients with HNF4A- and 35 patients with HNF1B-MODY were characterized and compared with patients <20 years old with type 1 diabetes (T1D)/type 2 diabetes (T2D). Main Outcome Measure: Clinical and laboratory parameters, therapy, metabolic control, and extrapancreatic symptoms in patients with HNF1B-MODY. Results: Patients with both MODY types were significantly older than patients with T1D at diagnosis (HNF4A, 13.8 years, and HNF1B, 13.5 years, vs T1D, 8.8 years; P < 0.0001). Mean C-peptide at diagnosis was higher for HNF4A-MODY than for T1D (1.8 vs 0.9 ng/mL; P < 0.01); 36.4% of patients with HNF4A-MODY and 65.7% of patients with HNF1B-MODY were treated with insulin, whereas 20.5% and 8.6% received oral antidiabetics only (P < 0.05 and P < 0.01 vs T2D). At the most recent visit, glycated hemoglobin levels were lower in HNF4A- and HNF1B-MODY (mean, 6.5% and 6.1%) than in T1D (7.9%; P < 0.0001). In 40% of patients with HNF1B-MODY, extrapancreatic symptoms were reported. Several clinical predictors previously described to differentiate between MODY and T1D or T2D were revalidated by logistic regression analyses in this cohort. Conclusion: The DPV registry enabled us to precisely characterize phenotype and treatment in these two rare MODY types. Although phenotype of HNF4A- and HNF1B-MODY showed distinct differences from those of T1D and T2D, 38% of patients were initially misclassified as having T1D or T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There are 14 genes that have been implicated as causes of MODY accounting for 11 different types of MODY.48,49”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Smoothing reference centile curves: The lms method and penalized likelihood
Cole, T. J., & Green, P. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111005 · Cited by 2,781
Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D., Geller, F., Geiß, H. C., Hesse, V., von Hippel, A., Jaeger, U., Johnsen, D., Korte, W., et al. (2001) · Monatsschrift Kinderheilkunde · doi:10.1007/s001120170107 · Cited by 2,175
Yates, A., Akanni, W., Amode, M. R., Barrell, D., Billis, K., Carvalho-Silva, D., Cummins, C., Clapham, P., Fitzgerald, S., Gil, L., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1157 · Cited by 1,273
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
Murphy, R., Ellard, S., & Hattersley, A. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0778 · Cited by 502
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
Ellard, S., Bellanné-Chantelot, C., Hattersley, A. T., & European Molecular Genetics Quality Network (EMQN) MODY group (2008) · Diabetologia · doi:10.1007/s00125-008-0942-y · Cited by 433
Pihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Definition, epidemiology, and classification of diabetes in children and adolescents
Craig, M. E., Jefferies, C., Dabelea, D., Balde, N., Seth, A., & Donaghue, K. C. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12186 · Cited by 366
Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Assessment and monitoring of glycemic control in children and adolescents with diabetes
Rewers, M. J., Pillay, K., de Beaufort, C., Craig, M. E., Hanas, R., Acerini, C. L., & Maahs, D. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12190 · Cited by 316
Blood Pressure Percentiles by Age and Height From Nonoverweight Children and Adolescents in Germany
Neuhauser, H. K., Thamm, M., Ellert, U., Hense, H. W., & Rosario, A. S. (2011) · Pediatrics · doi:10.1542/peds.2010-1290 · Cited by 281
Rafiq, M., Flanagan, S. E., Patch, A.-M., Shields, B. M., Ellard, S., Hattersley, A. T., & The Neonatal Diabetes International Collaborative Group (2008) · Diabetes Care · doi:10.2337/dc07-1785 · Cited by 265
Improved Metabolic Control in Children and Adolescents With Type 1 Diabetes
Rosenbauer, J., Dost, A., Karges, B., Hungele, A., Stahl, A., Bächle, C., Gerstl, E. M., Kastendieck, C., Hofer, S. E., Holl, R. W., et al. (2012) · Diabetes Care · doi:10.2337/dc11-0993 · Cited by 263
Self-citationBlood pressure in childhood: pooled findings of six European studies
de Man, S. A., Andr??, J.-L., Bachmann, H., Grobbee, D. E., Ibsen, K. K., Laaser, U., Lippert, P., & Hofman, A. (1991) · Journal of Hypertension · doi:10.1097/00004872-199102000-00002 · Cited by 246
Shepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236
Schütt, M., Kern, Krause, U., Busch, Dapp, A., Grziwotz, Mayer, I., Rosenbauer, Wagner, C., Zimmermann, et al. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924152 · Cited by 218
Self-citationThe diagnosis and management of monogenic diabetes in children and adolescents
Rubio-Cabezas, O., Hattersley, A. T., Njølstad, P. R., Mlynarski, W., Ellard, S., White, N., Chi, D. V., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12192 · Cited by 196
Schober, E., Rami, B., Grabert, M., Thon, A., Kapellen, T., Reinehr, T., & Holl, R. W. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02720.x · Cited by 182
Self-citationDubois-Laforgue, D., Cornu, E., Saint-Martin, C., Coste, J., Bellanné-Chantelot, C., Timsit, J., & for the Monogenic Diabetes Study Group of the Société Francophone du Diabète (2017) · Diabetes Care · doi:10.2337/dc16-2462 · Cited by 176
Bowman, P., Sulen, Å., Barbetti, F., Beltrand, J., Svalastoga, P., Codner, E., Tessmann, E. H., Juliusson, P. B., Skrivarhaug, T., Pearson, E. R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30106-2 · Cited by 175
Self-citationPrevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry
Irgens, H. U., Molnes, J., Johansson, B. B., Ringdal, M., Skrivarhaug, T., Undlien, D. E., Søvik, O., Joner, G., Molven, A., & Njølstad, P. R. (2013) · Diabetologia · doi:10.1007/s00125-013-2916-y · Cited by 136
Fendler, W., Borowiec, M., Baranowska-Jazwiecka, A., Szadkowska, A., Skala-Zamorowska, E., Deja, G., Jarosz-Chobot, P., Techmanska, I., Bautembach-Minkowska, J., Mysliwiec, M., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2621-2 · Cited by 129
Yorifuji, T., Nagashima, K., Kurokawa, K., Kawai, M., Oishi, M., Akazawa, Y., Hosokawa, M., Yamada, Y., Inagaki, N., & Nakahata, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0096 · Cited by 121
Holloway, M. G., Laz, E. V., & Waxman, D. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0328 · Cited by 110
Expanded Clinical Spectrum in Hepatocyte Nuclear Factor 1B-Maturity-Onset Diabetes of the Young
Raile, K., Klopocki, E., Holder, M., Wessel, T., Galler, A., Deiss, D., Müller, D., Riebel, T., Horn, D., Maringa, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2189 · Cited by 99
Self-citationMoss, A., Wabitsch, M., & Kromeyer-Hauschild, K. (2015) · Adipositas - Ursachen, Folgeerkrankungen, Therapie · doi:10.1055/s-0037-1618928 · Cited by 87
Ovsyannikova, A. K., Rymar, O. D., Shakhtshneider, E. V., Klimontov, V. V., Koroleva, E. A., Myakina, N. E., & Voevoda, M. I. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0192-9 · Cited by 56
Monogenic diabetes: Implementation of translational genomic research towards precision medicine
Vaxillaire, M., & Froguel, P. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12446 · Cited by 50
Treatment of young patients with HNF1A mutations (HNF1A–MODY)
Raile, K., Schober, E., Konrad, K., Thon, A., Grulich‐Henn, J., Meissner, T., Wölfle, J., Scheuing, N., Holl, R. W., & the DPV Initiative the German BMBF Competence Network Diabetes Mellitus (2015) · Diabetic Medicine · doi:10.1111/dme.12662 · Cited by 49
Self-citationAwa, W. L., Thon, A., Raile, K., Grulich-Henn, J., Meissner, T., Schober, E., Holl, R. W., & _, _. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0842 · Cited by 42
Self-citationAwa, W. L., Schober, E., Wiegand, S., Herwig, J., Meissner, T., Schmidt, F., Molz, E., & Holl, R. W. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.011 · Cited by 35
Self-citationMozzillo, E., Salzano, G., Barbetti, F., Maffeis, C., Lombardo, F., Franzese, A., Delvecchio, M., & Marigliano, M. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.003 · Cited by 31
Knerr, I., Dost, A., Lepler, R., Raile, K., Schober, E., Rascher, W., Holl, R. W., & Austria, O. B. O. T. D. D. A. S. F. P. S. (. S. I. G. A. (2008) · Diabetes Care · doi:10.2337/dc07-1392 · Cited by 31
Self-citationBacon, S., Kyithar, M. P., Condron, E. M., Vizzard, N., Burke, M., & Byrne, M. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0890-9 · Cited by 23
Algorithm-Based Cholesterol Monitoring in Children with Type 1 Diabetes
Schwab, K. O., Doerfer, J., Scheidt‐Nave, C., Kurth, B., Hungele, A., Scheuing, N., Krebs, A., Dost, A., Rohrer, T. R., Schober, E., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.12.038 · Cited by 21
Self-citationPOCT — Patientennahe Labordiagnostik
Luppa, P. B., Junker, R., & GmbH, S.-V. (2008) · Springer eBooks · doi:10.1007/978-3-540-79152-2 · Cited by 21
Diagnosis, Therapy and Control of Diabetes Mellitus in Children and Adolescents
Neu, A., Beyer, P., Bürger-Büsing, J., Danne, T., Etspüler, J., Heidtmann, B., Holl, R. W., Karges, B., Kiess, W., Knerr, I., et al. (2014) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0034-1366384 · Cited by 10
Self-citationWarncke, K., Kummer, S., Raile, K., Grulich‐Henn, J., Woelfle, J., Steichen, E., Prinz, N., & Holl, R. W. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5061/dryad.72d1v26 · Cited by 1
Self-citation
Research works printed but not linked: 2
- Glaser, 2003, GeneReviews®. Seattle (WA), 1993
- Schlebusch, 2008, POCT 2008. Patientennahe Labordiagnostik, 55
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Nkonge, K. M., Nkonge, D. K., & Nkonge, T. N. (2020) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-020-00112-5 · Cited by 178
Update on clinical screening of maturity-onset diabetes of the young (MODY)
Peixoto-Barbosa, R., Reis, A. F., & Giuffrida, F. M. A. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00557-9 · Cited by 116
Low, B. S. J., Lim, C. S., Ding, S. S. L., Tan, Y. S., Ng, N. H. J., Krishnan, V. G., Ang, S. F., Neo, C. W. Y., Verma, C. S., Hoon, S. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22843-4 · Cited by 84
Maturity Onset Diabetes of the Young—New Approaches for Disease Modelling
Skoczek, D., Dulak, J., & Kachamakova‐Trojanowska, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147553 · Cited by 48
Metadata
- Authors
- Warncke, K., Kummer, S., Raile, K., Grulich-Henn, J., Woelfle, J., Steichen, E., Prinz, N., & Holl, R. W.
- Affiliations
- TUM Klinikum (DE)
- Düsseldorf University Hospital (DE)
- Stiftung Charité (DE)
- Department of Pediatrics, University of Heidelberg, Heidelberg, Germany
- University of Bonn (DE)
- Innsbruck Medical University (AT)
- Universität Ulm (DE)
- Corresponding author
- Warncke, Katharina
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-12-10
- Volume
- 104
- Issue
- 3
- Pages
- 845-855
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2905492527
- Cited by
- 52
- References
- 41
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 5 · 2020: 9 · 2019: 2
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
- nbn-resolving.de
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Universität Ulm, Kommunikations- und Informationszentrum (kiz)
- Funders
- Federal Ministry of Education and Research within the German Center for Diabetes Research (82DZD0017G)
- INNODIA, supported by the European Union’s Horizon 2020 research and innovation program and “EFPIA”, ‘JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust (115797)
- Deutsche Diabetes Gesellschaft
- Robert Koch Institut
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HNF4A mutations, HNF1B mutations, hepatocyte nuclear factor, monogenic diabetes, HbA1c, insulin therapy, C-peptide, DPV registry, clinical phenotype
- MeSH terms
- Adolescent, Age Factors, Child, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diagnosis, Differential, Female, Humans, Hypoglycemic Agents, Insulin, Male, Prospective Studies, Registries, Rare Diseases, Hepatocyte Nuclear Factor 1-beta, Hepatocyte Nuclear Factor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.